North America Continuous Glucose Monitoring Systems (CGMS) Market is expected to grow at a CAGR of 28.1% during 2016-2022

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report, North America Continuous Glucose Monitoring Systems (CGMS) Market, published by KBV Research, the North America Continuous Glucose Monitoring Systems Market is expected to grow at a CAGR of 28.1% during 2016 -2022.

The Sensors market dominated the North America Continuous Glucose Monitoring Systems Market in 2015, and would grow at a CAGR of 29.4% during the forecast period. The U.S market registered the largest revenue share in the North America Continuous Glucose Monitoring Systems Sensors Market in 2015, and is expected to grow at a CAGR of 28.5% during the forecast period. The Canada market is expected to attain a market size of $146.5 million by 2022. However, Mexico market is expected to grow at CAGR of 31.1% during 2016-2022.

The Diagnostic centers/clinics segment is expected to attain a market size of $606.8 million by 2022. However, Home Healthcare market is expected to grow at CAGR of 40.2% during 2016-2022.The ICUs market followed the Diagnostic centers/clinics market in the North America Continuous Glucose Monitoring Systems Market in 2015.

The report highlights the adoption of Continuous Glucose Monitoring Systems (CGMS) in North America.Based on the Component, the Global Continuous Glucose Monitoring Systems Market is segmented into Sensors, Transmitters & Receivers and Integrated Insulin pumps segment. Based on the End user, the market is bifurcated into Diagnostic centers/clinics, ICUs and Home Healthcare segments. The countries included in the report are U.S, Canada, Mexico and Rest of North America region.

Key Players profiled in the report includes Roche Diagnostics, Abbott Laboratories, Dexcom Inc., Novo Nordisk, Ypsomed AG, GlySens Incorporated, Medtronic Plc and Johnson & Johnson.

Full report: https://www.kbvresearch.com/north-america-continuous-glucose-monitoring-systems-market/

Research Scope

The market is segmented based on Component, End User and Country.

North America Continuous Glucose Monitoring Systems Market, by Component

  • Hardware
  • Software
  • Services

North America Continuous Glucose Monitoring Systems Market, by End User

  • Displays Terminals
  • Interface Software
  • Industrial PCs
  • Other Controllers

North America Continuous Glucose Monitoring Systems Market, by Country

  • U.S
  • Canada
  • Mexico
  • Rest of North America

Company Profiles

  • Roche Diagnostics
  • Abbott Laboratories
  • Dexcom Inc.
  • Novo Nordisk
  • Ypsomed AG
  • GlySens Incorporated
  • Medtronic Plc and
  • Johnson & Johnson

Related Reports:

Europe Continuous Glucose Monitoring Systems Market

Asia Pacific Continuous Glucose Monitoring Systems Market

Global Continuous Glucose Monitoring Systems Market

Lamea Continuous Glucose Monitoring Systems Market

Request For Sample


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.